Locus Biosciences, Inc

Locus Biosciences, Inc., based in Raleigh, NC, is at the forefront of developing engineered bacteriophage therapies aimed at treating infectious diseases and addressing unmet medical needs in immunology, oncology, and CNS disorders. Utilizing a cutting-edge technology stack known as the LOCUS platform, the company combines robotics, AI, and synthetic biology to create precision medicines that outperform traditional phage therapies.

The company's innovative approach includes the clinical-stage investigational therapeutic ELIMINATE LBP-EC01, specifically designed to target E. coli infections. Supported by partnerships across academia, government, and the pharmaceutical sector, Locus Biosciences is committed to advancing the field of precision medicine.

Generated from the website